Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04949334
Other study ID # N202009012
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 23, 2021
Est. completion date July 15, 2023

Study information

Verified date September 2021
Source Taipei Medical University Shuang Ho Hospital
Contact Ruey Chen, PhD
Phone 886-2-2249088
Email 18622@s.tmu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

After acute ischemic stroke, the muscle strength of the limbs of the patients will decrease. Moreover, the respiratory muscles may also be affected. The respiratory muscle training may improve the respiratory recovery and prevent pulmonary complication.


Description:

After acute ischemic stroke, the muscle strength of the limbs of the patients will decrease. Moreover, the respiratory muscles may also be affected. The worsening of the respiratory function is weakened and lung function declines, leading to dysfunction of expectoration and swallowing, and increasing the incidence of pneumonia after stroke. In addition, it will also lead to a decline in activity ability, which in turn affects the quality of life. The respiratory muscle training may improve the respiratory recovery and prevent pulmonary complication.


Recruitment information / eligibility

Status Recruiting
Enrollment 144
Est. completion date July 15, 2023
Est. primary completion date January 15, 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria: 1. Ischemic stroke diagnosed by MRI 2. Age over 20 years old 3. No worsening of stroke or second stroke this time Exclusion Criteria: 1. Unable to understand instructions normally, or communication difficulties 2. Patients with endotracheal tube or tracheostomy 3. Angina in recent 3 months, myocardial infarction, heart failure 4. Patients with asthma or chronic obstructive pulmonary disease, spontaneous pneumothorax, and ongoing pneumonia 5. Patients with untreated hernias 6. Pregnant 7. Ongoing fever (body temperature>38.5°C) 8. Poor hypertension control (higher than 170/100 mmHg three days before intervention) 9. Patients who have had cerebral hemorrhage or aneurysm

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Dofin Breathing Strength Builder
If the patient's condition is stable, respiratory muscle training will be performed under Dofin Breathing Strength Builder 7 days after stroke. The patient will receive respiratory muscle training by repetition of 30 times, two courses per day, x 7 days, for three weeks. The initial load was set at 30% of the participants' maximal baseline strength and increased weekly at intervals of 2 cmH2O.

Locations

Country Name City State
Taiwan Shuang Ho Hospital, Taipei Medical University New Taipei City

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University Shuang Ho Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Respiratory muscle function-1.1 MEP (maximal expiratory pressure) Baseline
Primary Respiratory muscle function-1.2 MEP (maximal expiratory pressure) Within one week after training
Primary Respiratory muscle function-1.3 MEP (maximal expiratory pressure) Twelve weeks after training
Primary Respiratory muscle function-2.1 MIP (maximal inspiratory pressure) Baseline
Primary Respiratory muscle function-2.2 MIP (maximal inspiratory pressure) Within one week after training
Primary Respiratory muscle function-2.3 MIP (maximal inspiratory pressure) Twelve weeks after training
Secondary Dyspnea.1 Dyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition. Baseline
Secondary Dyspnea.2 Dyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition. Within one week after training
Secondary Dyspnea.3 Dyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition. Twelve weeks after training
Secondary Exercise tolerance.1 Exercise tolerance assessed by six-minute walk test (6MWT). Baseline
Secondary Exercise tolerance.2 Exercise tolerance assessed by six-minute walk test (6MWT). Within one week after training
Secondary Exercise tolerance.3 Exercise tolerance assessed by six-minute walk test (6MWT). Twelve weeks after training
Secondary Body composition.1 Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA). Baseline
Secondary Body composition.2 Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA). Within one week after training
Secondary Body composition.3 Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA). Twelve weeks after training
Secondary Life quality.1 Quality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality. Baseline
Secondary Life quality.2 Quality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality. Within one week after training
Secondary Life quality.3 Quality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality. Twelve weeks after training
Secondary Swallowing.1 Swallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition. Baseline
Secondary Swallowing.2 Swallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition. Within one week after training
Secondary Swallowing.3 Swallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition. Twelve weeks after training
See also
  Status Clinical Trial Phase
Recruiting NCT03993236 - Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke Phase 4
Completed NCT04069767 - Innovative Physiotherapy in Stroke Rehabilitation N/A
Recruiting NCT06342206 - The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Enrolling by invitation NCT04956211 - Periodontal Treatment and Ischemic Stroke N/A
Active, not recruiting NCT05098236 - Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage N/A
Completed NCT03942588 - High-intensity Interval Training After Stroke N/A
Terminated NCT04095767 - Assessing Safety and Performance of the ANA Catheter System, Combined With a Stent Retriever in Acute Ischemic Stroke N/A
Not yet recruiting NCT06352086 - Understanding Visual Processing After Occipital Stroke
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Completed NCT01937182 - The Efficacy of Citalopram Treatment in Acute Stroke Phase 2
Completed NCT03649295 - Combined Conventional Speech Therapy and Functional Electrical Stimulation in Dysphagia Following Stroke N/A
Recruiting NCT05303649 - Effects of Neuronavigated Theta Burst Stimulation in Therapy of Post-stroke Aphasia N/A
Completed NCT04233515 - Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County
Completed NCT05102877 - Sensory Versus Motor Level Neuromuscular Electrical Stimulation N/A
Completed NCT04089917 - A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients
Completed NCT05221112 - Effects of PNF Patterns Training on Trunk Balance, and Gait in Chronic Stroke Patients N/A
Not yet recruiting NCT05035953 - Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke Phase 2
Completed NCT06326801 - Resistive Diaphragmatic Breathing Exercise With Pursed Lips Breathing Exercise in Sub-acute Stroke Patients N/A
Recruiting NCT03826030 - Transcranial Direct Current Stimulation for Post-stroke Motor Recovery Phase 2